康涅狄格州吉尔福德 - 拥有强健资产负债表、现金多于债务的先锋健康科技公司Hyperfine, Inc. (NASDAQ: HYPR )宣布其最新创新产品——一款由专有Optive AI™软件增强的新型便携式MRI扫描仪获得FDA批准。这一进步将改善临床医生和患者的便携式MRI体验，在各种医疗环境中提供高质量的大脑成像。根据 InvestingPro ...

Hyperfine HYPR recently announced FDA 510(k) clearance for its next-generation Swoop Portable MR Imaging system. The ...

Hyperfine (Nasdaq:HYPR) announced today that the FDA cleared its latest portable MRI scanner powered by proprietary AI ...

Updated daily, Benzinga’s Top Stock Leaderboards highlight our best buys right now. Spot breakout opportunities before the ...

This clearance is the most significant innovation in the history of Hyperfine. We plan to launch the new Swoop® system across hospital and office settings in the US, and we believe the new Swoop ...

Hyperfine计划从2025年第三季度开始向其客户分发Optive AI™软件。Swoop®便携式MR成像®系统已获FDA批准用于所有年龄段的脑部成像，其便携性和在传统全诊断检查可能不可行的各种专业护理环境中提供MR成像的能力尤为显著。

近日，全球便携式MRI巨头Hyperfine宣布，宣布任命医疗器械行业资深人士 Maria Sainz 为总裁兼首席执行官（CEO），自2022年10月24日起生效。目前担任临时 ...

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality This major Swoop® system scanner rede ...

Hyperfine (HYPR) announced FDA clearance that includes an entirely new portable MRI scanner powered by the proprietary Optive AI software. The ...

Hyperfine, Inc. announced its fourth quarter and full year 2024 financial results, highlighting key achievements and future plans. CEO Maria Sainz expressed satisfaction with progress made in the ...